Monday, August 26, 2019

Snapshot looking at #Cannabis #Stocks in #Nevada: #Payment #Tech Solutions to #Retail Deals (OTC: $GOHE), (OTCQX: $TRTC), (TSXV: $NRTH.V) (OTC: $NCNNF), (CSE: $TGIF.C) (OTC: $TGIFF)

Snapshot looking at #Cannabis #Stocks in #Nevada: #Payment #Tech Solutions to #Retail Deals (OTC: $GOHE), (OTCQX: $TRTC), (TSXV: $NRTH.V) (OTC: $NCNNF), (CSE: $TGIF.C) (OTC: $TGIFF)

Point Roberts WA, Delta, BC –August 26, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the recent developments occurring in the Nevada cannabis market as it matures and expands. 

recent news report discussing the potential of the Nevada market versus the California market mentioned, “a more intriguing metric offered in State of the Legal Cannabis Markets -- spending per capita -- suggesting that another state could blow California out of the water in terms of attractiveness to businesses and investors: Nevada.”

The article continued, “Between 2018 and 2024, Arcview and BDS are forecasting that Nevada's population will increase by about 10% to 3.4 million. Yet, with the Silver State opening its doors to recreational marijuana sales in July 2017, total legal spending is expected to surge from $567 million in 2018 to $1.41 billion by 2024. On a per-capita basis, this works out to $415.57 in spending. That's more than double California ($172.08), and is higher than every other state in the country. It's no secret that Nevada's exceptionally high spending per capita forecast stems from the state's strong tourism. Las Vegas is a core attraction for Americans and visitors from all over the world, which should allow cannabis companies to focus their attention on Sin City to drive sales and margins. Plus, Nevadans are faced with a combined 25% tax rate, including a 15% tax on wholesale sales, and 10% on retail sales. That's significantly less than neighboring California, which should help reduce illicit production.”

Assuming Arcview's and BDS Analytics' projections prove relatively accurate, there are a number of ways to play the most lucrative market in the United States.

Global Payout Inc. (OTC: GOHE), through its Nevada based subsidiary MTrac Tech Corporation, provides electronic wallet and e-banking financial solutions for the marijuana industry, recently announced that the company has retained one of the nation’s leading government affairs organizations, Strategies 360, to further the platform’s legislative push to be recognized as the most innovative and seamless SaaS (Software as a Service) solution to facilitate cashless, compliant, and secure payments for the legalized cannabis industry.

Headquartered in Seattle, WA, S360 represents a broad range of sectors with an expanding footprint in 12 western states and DC. The S360 team is comprised of some of the brightest, forward-thinking former executives from various industries, such as technology, finance and energy, in addition to former state public office holders.


One of the primary goals of the MTrac platform has been to assist governments in their efforts to both regulate the cannabis industry and solve the issues associated with cash heavy transactions and a lack of available banking resources. Some states have recently been exploring closed-loop systems to implement statewide regulatory oversight of legal cannabis operations. For example, the state of Arizona has opened a “Fintech” sandbox, allowing various closed-loop systems into the Arizona market on a limited basis to see how well they operate. Nevada will very shortly, be opening a Request for Proposal to find a closed-loop, blockchain platform that will allow their cannabis industry to accept digital payments. It is the opinion of management that the MTrac system is the most seamless version of this payment platform available and offers the added benefit of having a large and growing customer base to provide proof of concept, similar to the recent state-wide launch in Louisiana. 

“The agreement with S360 could not have been timelier in terms of presenting our solution to the western region, to showcase the features and functionality of the platform’s closed-loop eWallet accounts for the states’ lawmakers.” said Mr. Jason LeBlanc, Chief Compliance Officer of MTrac. “We are extremely excited to be working with such a dynamic and results-driven government affairs team. The opportunity to present our platform at the highest levels of state regulators and legislators is an objective that our legal and compliance teams have been working toward for the last several months, and the partnership with S360 is now making this opportunity a reality.”

The Company looks forward to working closely with the S360 team to introduce its payment platform to the western states and will keep shareholders apprised of its progress at regular intervals.

Terra Tech Corp. (OTCQX:TRTC), a vertically integrated cannabis-focused agriculture company, recently announced that it has entered into an agreement to sell 100% of the assets of its Blüm Reno dispensary, located at 1085 S Virginia St. Suite A, Reno, NV 89502, including the building where the dispensary is located, for a purchase price of $15,000,000.

Terra Tech’s Blüm Reno dispensary has been operational since January 2017 and provides cannabis products to the local medical and adult-use markets, including the Company’s proprietary IVXX™ brand of premium medical cannabis, flowers, shatters, waxes and oils, among other high-quality cannabis products from a range of reputable providers of superior grade medical cannabis.

Derek Peterson, CEO of Terra Tech, commented, ''Selling the cannabis retail license for our Blüm Reno dispensary is another key milestone in our restructuring plan, a strategy that has been implemented to leverage our balance sheet to fuel growth, as opposed to approaching the capital markets more often than is necessary. Our Blüm dispensary in Reno has substantially increased in value since its opening, and selling its assets allows the Company to strategically monetize this asset. To move forward with our restructuring strategy, we plan to redeploy the additional capital generated by this sale toward more productive assets in California in areas such as infrastructure and sales and marketing.”

Terra Tech anticipates the closing of the transaction within 90 days, pending all state and local jurisdictional approvals.

The Nevada market is also starting to attract more Canadian companies such as 48North Cannabis Corp. (TSXV: NRTH) (OTC: NCNNF), who is hoping to enter into the Nevada market soon, as the company recently signed a definitive agreement to acquire Rare Industries, Inc., also known as Quill, a vape technology brand.

Quill’s products are being distributed in Oregon and Washington, with plans to reach California and Nevada. The company said this acquisition is its first attempt to reach the US.

"48North recognizes the importance of entering the burgeoning US market. I believe that authentic brands and next-generation products distributed at scale, particularly in the emerging US market, will be one of the major keys to success in the cannabis industry," Alison Gordon, co-CEO of 48North said in a statement. "Without question, the Quill suite of products aligns closely with 48North's growing portfolio of brands.”

The total purchase price was set to $2.1 million out of which $641,000 is cash and $1.46 million is in the form of 48North’s common shares at a price of around 86 cents per share, the company reported.

48North plans to utilize Quill’s distribution network to promote its portfolio of brands in the US, and also to sell Quill’s products via its distribution networks in Canada.

"48North's industry-leading focus on next-generation cannabis products and its brand-first consumer strategy will undoubtedly elevate Quill, its brand and products to the next-level. The US-based Quill team is eagerly looking forward to joining with 48North's experienced and dedicated management team," said Ian Van Vaughan Shaughnessy, co-founder of Quill.

1933 Industries Inc. (CSE: TGIF) (OTC: TGIFF), a vertically integrated cannabis consumer packaged goods company, recently commenced the transfer of cannabis plants to its new cultivation facility in Las Vegas following an extensive period of systems-wide testing.

"This is a brand new facility and we worked around the clock to ensure that all systems were operational before transferring our plants,'' commented Mr. Tim Spencer, Director of Cultivation. The new facility allows the Company to cultivate five times the amount of cannabis flower that was previously produced to meet the high demand for its branded flower and concentrate products under the Alternative Medicine Association (AMA) line, which are sold in licensed dispensaries in Nevada. AMA also produces well-known brands such as Gotti's Gold, Kurupt's Moonrocks, and Denver Dab Co. under licensing agreements. The increased flower production in the new facility will meet growing demand for premium cannabis products and will have a significant impact on the Company's bottom line.

The Company will welcome OG DNA Genetics (DNA), a globally recognized leader in the research and development of cannabis genetics, to its new facility. DNA selected AMA as its partner in Nevada due to the Company's advanced facility, extensive distribution channels and high-quality standards. DNA will provide specific expertise to AMA for the development of a consistent phenotype strain for a new line of co-branded flower and pre-rolls.

"We have constructed a one-of-a-kind, purpose-built facility, integrated with the latest technology to increase yields, bolster plant health and assure the consistency and quality of our products,'' said Mr. Chris Rebentisch, CEO of 1933 Industries Inc. "As experienced cultivators, we understand that controlling the growing environment is the most important part of cultivating high-quality craft cannabis at scale, which is why we spent significant time, capital and management's time, to build a state-of-the-art indoor facility. We are investing in assets that will provide a continuous supply of the raw materials necessary to produce our premium cannabis products and improve our margins.”

In order to verify that the plants are receiving exact amounts of nutrients and moisture content, the facility was outfitted with drip automation in order to standardize cultivation techniques and implement efficient watering and feeding systems with waste reduction in mind. "We can exactly measure the water and air content, meaning we are driving each plant's growth with actual data instead of subjective opinion. This level of refinement is further testament to our commitment to consistent quality," added Mr. Spencer.

Once the cannabis plants are situated in the new facility, they will vegetate for approximately four weeks before the flower cycle is begun for another eight weeks. The next steps include harvesting, drying, packaging and third-party testing. The entire cycle takes approximately 16 weeks.

As the Nevada market expands in population and as more cannabis related infrastructure develops we can expect it to become a rival, if not overbearing market in comparison to the already massive California market. State tax and regulation changes could also play an important role moving forward as federal legalization remains out of reach in the US.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Disclaimer/Disclosure
Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring GOHE is a paid for news release on Investorideas.com – third party (two thousand)  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com
800-665-0411





Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Friday, August 23, 2019

Investorideas.com - Timeless (TSXV: TLC.P) Enters into Definitive Agreement for Qualifying Transaction with CannaVerde

Investorideas.com - Timeless (TSXV: TLC.P) Enters into Definitive Agreement for Qualifying Transaction with CannaVerde

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: $APHA.TO) (NYSE: $APHA) Files Preliminary Base Shelf Prospectus

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: $APHA.TO) (NYSE: $APHA) Files Preliminary Base Shelf Prospectus

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (TSX: $AVCN.CA) (TSXV: $NRTH.V) (OTC: $KALY)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (TSX: $AVCN.CA) (TSXV: $NRTH.V) (OTC: $KALY)



Delta, Kelowna, BC –August 23, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, Geocann announced that the company has successfully commercialized the first CBG soft gel products that utilize the multi-patented VESIsorb® delivery system for optimal absorption and measured bioavailability. The initial step is utilizing proprietary extraction technology to isolate and concentrate the CBG that allows Geocann to use its technical formulation expertise to address the active ingredient’s performance as it relates to dissolution, absorption, and bioavailability.

The first of two formulations is a combination of CBG and cannabidiol (CBD) while the second is a mono-CBG formulation. Both products include strategic inclusions of beta-caryophyllene (BCP) which has been shown to have synergistic effects as agonists for the CB2, 5-HT1A and glycine receptors.

“These product launches further advance Geocann’s leadership position as product development specialists that provide science-backed solutions to the industry’s formulation challenges,” said Marc Weder, Chief Scientific Officer. “The marketplace is demanding advancements beyond just CBD products and we are supremely positioned to deliver these solutions with more than three decades of research and product development expertise.”

Weder states that while the interest is high to include CBG (and other emerging cannabinoids and terpenes) in new formulations, the poor solubility and dissolution must be addressed to provide superior product solutions with the optimized absorption, bioavailability, and maximum therapeutic benefits consumers are seeking.

“Geocann has accomplished these results and has successfully transferred a rigorous product development protocol to the large-scale commercial production of soft gel capsules, topicals, foods, beverages, and sublinguals that combine these active ingredients with the VESIsorb® technology,” said Weder.

Geocann has worldwide exclusivity for cannabinoids formulated with VESIsorb®, and the company is quickly partnering with strategic brand leaders in key channels of distribution to deliver its robust portfolio of patent-protected products.

“The combination of CBD, CBG, and BCP powered by VESIsorb® in an elegant soft gel capsule is an important industry milestone,” said Jesse Lopez, CEO and founder. “Geocann will continue to pioneer the advancement of new cannabinoids, like CBG, CBN, and THCV, as it’s a privilege to offer these first-to-market opportunities to our brand partners.”


Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNFprovided an update on its cultivation and production operations near Ibague, Colombia, where it has achieved significantly expanded analysis, extraction and purification capabilities across its cultivation facility.
Khiron currently owns and operates one of the most sophisticated medical cannabis cultivation and processing facilities in Latin America. Building on the completion of the facility announced on June 2, 2019, the state-of-the-art, 14,000 square foot GMP and ISO 17025 compliant lab now includes full capabilities in the following:
  
     Ultra high and High performance liquid chromatography ("UHPLC & HPLC") technology, gas chromatography technology, microbiology testing, and heavy metals for testing flower and extract samples –Through the use of these in-house techniques, Khiron can quickly and accurately analyze samples, identify active cannabis components, and ensure that the products are extracted and purified to meet local regulations on THC and CBD concentrations.
     Stability testing – Stability tests provide evidence on how cannabis products vary over a given time period and under the influence of environmental factors. Khiron currently has robust stability testing capacities in place, with studies designed to evaluate and ensure the quality, safety and efficacy of its products, across various stages of extraction, as well as final product.  In Colombia, stability data is needed to receive quotas for the production and domestic commercialization of THC extracts. As part of the Company's commitment to high quality standards, stability testing for extracts and final products are necessary before shipping product to consumers.
     Vertical integration – Leveraging the Company's cultivation, extraction and purification capabilities, Khiron has the ability to manage all stages of cannabis production, from soil to flower to extract, entirely within its own facility.  Its vertically integrated capabilities serve to maximize efficiency and reliability across the cannabis supply chain, allowing the Company to streamline operations as it moves towards the sale and distribution of its products.
  
Alvaro Torres, Khiron CEO and Director, stated, "With advanced analysis, extraction and purification capabilities in place, the company has performed  the analytical and stability tests required by the authorities to launch medical products and we remain on track for full commercialization of the grow site, anticipated in Q3 2019. Our significant investment in the Company's Ibague facility, primarily to target a market of 6 million patients in Colombia, ensures Khiron remains focused on its core strategy to serve the domestic market in Latin America."
Through scalable and flexible operations, the Company has designed its cultivation capabilities to work within the most up-to-date country quota to meet domestic demand, including to serve more than 119,000 patients at the Company's IILANS clinics. Based on the total allocation to the country, the Government of Colombia allocates annual quotas reflecting the operational plan and production estimates as outlined in the licence submissions, with the ability to request additional capacity to meet market demands. Country production quotas for 2020 will be announced by the INCB in January 2020.

Avicanna Inc. (TSX: AVCN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announced that its subsidiary, Santa Marta Golden Hemp S.A.S., has completed its first export of purified CBD from Colombia to Canada for research and development purposes.

Aras Azadian, Chief Executive Officer of Avicanna commented "We are thrilled to complete our first export and proud to be doing so into Canada. This is another validation of Avicanna's ability to execute on all of its verticals and demonstrates the success and advantage of Avicanna's cultivation infrastructure, extraction and purification capacity, and regulatory expertise."

Health Canada issued three authorizations to SMGH on June 28, 2019 to allow for the import of CBD isolates and cannabis resin into Canada from Colombia for scientific purposes. The CBD isolates cleared Colombian border procedures and were exported from Colombia on August 22, 2019.

48North Cannabis Corp. (TSXV:NRTHannounced that it has entered into a definitive agreement dated August 22, 2019 to acquire Rare Industries, Inc. ("Quill"), a U.S. multi-state Vape Technology brand with product distribution in Oregon and Washington and near-term expansion plans for California and Nevada. The acquisition marks 48North's first foray into the United States.

Quill, a leader in the manufacturing of beautifully designed, lifestyle-focused and sleek vape products, specializes in the development of easy-to-use, controlled-dosage and health-focused disposable vape pens.

Quill distributes its unfinished branded proprietary vape delivery hardware to licensed cannabis processors who finish the products (including by filling the hardware with cannabis extracts) and distribute the finished products to licensed cannabis retailers. Quill is not itself engaged in the cultivation, distribution or possession of cannabis in the United States.

This year, in addition to Quill's established products, the company is launching a full-spectrum, hemp based, CBD-specific, internationally distributed, all-in-one vaporizer pen. As a result, 48North-owned products will now have multi-state distribution and the ability to be licensed globally, where legally permitted.

"48North recognizes the importance of entering the burgeoning U.S market. I believe that authentic brands and next-generation products distributed at scale, particularly in the emerging U.S. market, will be one of the major keys to success in the cannabis industry," said Alison Gordon, co-CEO of 48North.

"Without question, the Quill suite of products aligns closely with 48North's growing portfolio of brands. This acquisition marks a critical step in the Company's goal to become the trusted leader in the development, manufacturing and distribution of next-generation cannabis products and brands," Ms. Gordon continued.

48North intends to leverage Quill's expanding distribution network to accelerate the distribution of the Company's brand portfolio into the United States. 48North also intends to pursue opportunities to sell Quill products throughout its existing distribution network in Canada.

Kali-Extracts, Inc. (OTC: KALYpublished a new website dedicated to providing information on the company’s recently introduced CBD Formulation, RespRx, for the treatment of Chronic Obstructive Pulmonary Disease (COPD) affecting 65 million people worldwide. 

KALY introduced the new CBD Formulation earlier this week after making a patent application and trademark registration for the formulation.  The website will be continually updated with information about the patent and application trademark progress and the ongoing RespRx medical trials and developments as the company advances toward FDA approval.

In the fourth quarter of last year, 2018, KALY acquired NCM Biotech (NCMB).  NCMB owns and operates a U.S. Patent for cannabis extraction process.  With the acquisition of NCMB, KALY is now primarily in the business of developing biopharmaceutical formulations from cannabis extractions for the treatment of various diseases.  KALY now has over four years of research and development behind cannabis extract formulations targeting the treatment of Chronic Obstructive Pulmonary Disease (COPD), Cancer Pain Management, Type 2 Diabetes and Epilepsy.

KALY has implemented a long-term sustainable overall business strategy.  KALY is not just relying on its biopharmaceutical development strategy alone to insure the company’s long-term success.  KALY, through partnership and independently, has also introduced to market a number of CBD infused consumer food products and a new CBD extraction service for hemp farming operations.

The revenue realized in the first six months of 2019 comes primarily from KALY’s various CBD infusion offerings.  KALY realized $165,000 in revenue in the first six months of 2019.  The revenue results from the company’s cannabis business shift in the fourth quarter of last year.  In the first six months of 2018, KALY reported only $46,000 in sales.  The introduction of KALY’s new cannabis business has seen the company’s revenue grow over 250% in the first six months of 2019 compared to the first six months of 2018.  KALY also realized $70,000 in operating net income in the first six months of 2019.  KALY reported only nominal operating net income in the first six months of 2018.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories


Investor Ideas adds New #Stocks in Cannabis (NYSEArca: $THCX) (CSE: $AYR.A.C) (OTCQB: $SEDO) and Entertainment (TSXV: $WNDR.V) (OTC: $WDRFF)

Investor Ideas adds New #Stocks in Cannabis (NYSEArca: $THCX) (CSE: $AYR.A.C) (OTCQB: $SEDO) and Entertainment (TSXV: $WNDR.V) (OTC: $WDRFF)




Point Roberts WA, Delta BC, August 23, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in cannabis and entertainment.


The newest cannabis companies include a US-listed Cannabis ETF, a cannabis company focused on recreation and wellness applications in the US and a tech company providing automated indoor growing solutions for the hemp and agriculture sectors.

The latest entertainment company’s main business is the production of high-quality feature films and episodic television that offer international appeal through the Company's guiding philosophy of bringing new financing solutions to an entertainment industry increasingly looking for funding and co-production alternatives.

New Cannabis Companies:
The Cannabis ETF (NYSEArca:THCX) tracks the Innovation Labs Cannabis Index, which is a modified market capitalization weighted index, with a portfolio of 36 stocks that are expected to benefit from growth of the legal marijuana, CBD and hemp industries. Valens' inclusion is part of THCX's expansion to include various cannabis industry sub-themes, such those at the crossroads of science and technology, which is intended to appeal to investors who are looking for differentiated exposure outside of a traditional seed-to-sale story. The index rebalances on a monthly basis and it is currently considered the lowest cost passively managed US-listed cannabis ETF.

Ayr Strategies Inc. (CSE: AYR.AAYR.WTAYR.RT) is a vertically-integrated cannabis company in the United States focused on recreational and wellness applications, with an initial anchor portfolio of vertically-integrated operations in the Eastern and Western United States.

Seedo Corp. (OTCQB: SEDO) is a market leading, high-tech company providing the hemp and agriculture industries with fully automated and controlled indoor growing solutions for home-grown and commercial hemp, herbs and vegetables. Seedo provides growers with the freedom to cut costs while generating high yields of lab-grade, pesticide-free herbs and vegetables. Seedo's artificial intelligence (AI)-powered, turnkey systems enable anyone, from the average consumers to large-scale producers, the ability to grow without prior experience or ample space. The Seedo solution minimizes cultivation costs by delivering maximum daylight illumination, built-in carbon filters, automated air conditioning, and a smart post-harvest drying system to users. Even in the harshest environments or with limited space, cultivators can use Seedo's intelligent technology to harvest the next generation of precision agriculture.

New Entertainment Companies:
Wonderfilm Media Corporation, The  (TSXV: WNDR.V) (OTC: WDRFF) is a leading publicly traded (TSX Venture Exchange) entertainment company with offices in Beverly Hills, Vancouver, Canada and Seoul, South Korea. Wonderfilm's main business is the production of high-quality feature films and episodic television that offer international appeal through the Company's guiding philosophy of bringing new financing solutions to an entertainment industry increasingly looking for funding and co-production alternatives. Wonderfilm is a producer and distributor only for the projects disclosed. The legal ownership of movie productions is held in a special purpose legal entity held at arm's length to the Company to facilitate for the qualification of various levels of domestic and foreign government tax credit incentives that are customary in the film and production business.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411